BIO FPX 1000 Assessment 6 Patient Case Study Profiles – Cancer Causes

Name

Capella university

BIO FPX 1000 Human Biology

Prof. Name

Date

BIO FPX 1000 Assessment 6 Patient Case Study Profiles – Cancer Causes

Breast cancer risk is influenced by a combination of genetic, reproductive, hormonal, lifestyle, and personal health factors. In the BIO FPX 1000 Assessment 6 patient profiles, Mary, Paula, June, and Nora each have different characteristics that may affect their breast cancer risk. Family history, especially breast cancer in a close relative at a young age or a known BRCA1 or BRCA2 mutation, is particularly important. Other factors include age, reproductive history, menopausal hormone therapy, alcohol consumption, physical activity, body weight, and certain inherited genetic changes. Because risk varies among individuals, breast cancer screening and prevention should be based on a person’s complete medical and family history rather than one risk factor alone.

Mary: Breast Cancer Risk Factors

Mary is 64 years old. She had her first child at age 20, experienced menopause at age 58, used estrogen replacement therapy for approximately six years after menopause, and later gained weight. Her mother developed breast cancer at age 37, and Mary experienced menarche at age 13.

The most significant concern in Mary’s history is her mother’s breast cancer diagnosis at a relatively young age. A first-degree relative, such as a mother or sister, with breast cancer can increase a person’s risk. The concern may be greater when the relative developed cancer at a younger age because early-onset breast cancer can sometimes indicate an inherited predisposition.

Mary’s history of postmenopausal hormone therapy and subsequent weight gain may also contribute to her overall risk. The relationship between menopausal hormone therapy and breast cancer depends on the type of hormones used, duration of treatment, timing, and individual characteristics. Excess body weight after menopause is also associated with increased breast cancer risk.

Mary’s Breast Cancer Risk Assessment

Risk assessment tools can estimate a person’s likelihood of developing breast cancer over a specific period or during their lifetime. However, different calculators use different factors and can produce different results. A risk score should therefore be interpreted alongside Mary’s personal and family history.

Because Mary’s mother developed breast cancer at age 37, Mary may benefit from genetic counseling. A genetic counselor can review her family history and determine whether testing for hereditary breast cancer genes, including BRCA1 and BRCA2, is appropriate.

Recommendations for Mary

Mary should discuss her family history, previous hormone therapy, and other risk factors with her healthcare provider. Her provider can determine which screening approach is appropriate based on her age and estimated risk.

Depending on her overall risk, screening may include routine mammography. Women who are determined to have a sufficiently high lifetime risk may also be candidates for supplemental screening, such as breast MRI.

Lifestyle changes can address some modifiable risk factors. Mary can discuss maintaining a healthy body weight, exercising regularly, limiting alcohol consumption, and following a balanced dietary pattern with her healthcare provider.

Menopausal hormone therapy should not be used specifically to prevent breast cancer. If hormone therapy is being considered for menopausal symptoms, the potential benefits and risks should be evaluated individually.

Paula: Breast Cancer and Hereditary Cancer Risk

Paula is 71 and is being treated for bladder cancer that has spread to her ovaries and lymphatic system. Her sister was treated for breast cancer three years ago. Her mother died from lung cancer, and Paula reports cancer diagnoses in two paternal uncles and her maternal grandmother.

The presence of cancer among several relatives raises the possibility of a hereditary cancer syndrome. The concern is particularly important because Paula’s sister reportedly carries a BRCA1 mutation.

BRCA1 and BRCA2 are tumor-suppressor genes. Certain pathogenic variants in these genes can substantially increase the risk of breast, ovarian, and other cancers. However, having several relatives with cancer does not automatically mean that Paula has an inherited mutation.

Paula’s Breast Cancer Risk Assessment

A known BRCA1 mutation in a close relative provides a strong reason for Paula to discuss genetic counseling and testing with her healthcare team.

A genetic counselor can review her family’s cancer history, determine whether testing is appropriate, and explain what the results could mean for Paula and potentially for her relatives.

If Paula carries the same familial BRCA1 mutation, her healthcare providers can develop an individualized cancer surveillance and risk-management plan. Her existing cancer diagnosis, age, treatment status, overall health, and personal preferences should all be considered.

Recommendations for Paula

Paula’s immediate cancer treatment should remain under the direction of her oncology team. Treatment decisions should be based on the type and stage of her cancer, pathology, molecular characteristics, previous treatment, and overall health.

Chemotherapy may be appropriate for some patients with bladder cancer, but it should not be recommended simply because a person has a family history of breast cancer or a BRCA mutation. Depending on the specific cancer, treatment may involve chemotherapy, immunotherapy, targeted therapy, surgery, radiation, or a combination of approaches.

Genetic counseling is especially relevant because of Paula’s sister’s reported BRCA1 mutation. Paula should also discuss whether additional breast surveillance is appropriate for her individual risk profile.

June: Breast Cancer Risk Factors

June is 58 and receives regular mammograms. Her family history includes an aunt with breast cancer and a mother who had a brain tumor. June also has hypertension, elevated cholesterol, and fragile bones.

An aunt is a second-degree relative, so her breast cancer history generally carries less hereditary significance than breast cancer in a first-degree relative such as a mother or sister. However, the age at which June’s aunt developed breast cancer and whether other relatives have had cancer could provide additional information.

The type of brain tumor experienced by June’s mother is also important. Not all brain tumors are associated with hereditary breast cancer syndromes, so the specific diagnosis and broader family history should be reviewed before drawing conclusions about genetic risk.

June’s history of oral contraceptive use may also be considered when evaluating her overall risk. Research suggests that current or recent hormonal contraceptive use may be associated with a small increase in breast cancer risk, although the relationship is complex and varies according to individual circumstances.

Recommendations for June

June should continue breast cancer screening according to recommendations appropriate for her age and personal risk. For women at average risk, mammography is performed at regular evidence-based intervals. More intensive screening may be considered when a person has a substantially elevated lifetime or hereditary risk.

Very frequent mammography is not generally recommended for routine screening. Screening every few weeks or every 40 days, for example, is not a standard breast cancer screening schedule.

June should also address her other health conditions. Managing hypertension and elevated cholesterol can reduce cardiovascular risk. A balanced eating pattern, regular physical activity, and other lifestyle measures may support overall health.

Her fragile bones also deserve medical attention. Depending on her clinical history, her healthcare provider may recommend osteoporosis evaluation, adequate calcium and vitamin D intake, weight-bearing exercise, or medication when appropriate.

Nora: Breast Cancer Risk Factors

Nora is 51 and has not yet reached menopause. Her family history includes both breast cancer and colon cancer. The case estimates her lifetime breast cancer risk at 23.8%, which is higher than the average risk for women in a comparable population.

A family history that includes breast and colon cancer may warrant closer evaluation, but its significance depends on several details. These include which relatives were affected, their ages at diagnosis, the specific types of cancer, and whether additional cancers occur within the family.

Nora’s Breast Cancer Risk Assessment

A calculated lifetime breast cancer risk of approximately 23.8% may place Nora above the commonly used 20% lifetime-risk threshold for considering enhanced breast screening, provided the estimate was generated using an appropriate validated risk model.

Different breast cancer risk models use different variables and may produce different estimates. Therefore, Nora’s reported percentage should be interpreted by a qualified healthcare professional rather than treated as an absolute prediction.

Because of her family history and elevated estimated risk, Nora should consider genetic counseling. Genetic testing may be appropriate if her family history meets established criteria, but testing should be guided by a healthcare professional or genetic counselor.

Recommendations for Nora

Nora should discuss her family history and calculated lifetime risk with her healthcare provider. If genetic testing identifies a pathogenic variant associated with hereditary breast cancer, her screening and risk-reduction plan can be adjusted accordingly.

Healthy lifestyle choices may also help reduce modifiable cancer risk. These include maintaining a healthy weight, engaging in regular physical activity, avoiding tobacco, and limiting alcohol consumption.

Nora should also review her reproductive and hormonal history with her healthcare provider. Factors such as age at first full-term pregnancy, age at menarche, menopausal status, and hormonal contraceptive use can contribute to breast cancer risk assessment.

Key Breast Cancer Risk Factors in These Patient Profiles

The four BIO FPX 1000 Assessment 6 cases demonstrate that breast cancer risk is multifactorial. Some factors are nonmodifiable, while others can potentially be addressed through lifestyle or medical interventions.

Important risk factors represented in these cases include:

• Increasing age.

• A mother, sister, or other relative with breast cancer.

• Breast cancer diagnosed in a close relative at a young age.

• Inherited pathogenic variants such as BRCA1 or BRCA2.

• Certain reproductive and hormonal factors.

• Some forms of menopausal hormone therapy.

• Alcohol consumption.

• Physical inactivity.

• Excess body weight, particularly after menopause.

• A personal history of certain cancers or high-risk breast conditions.

• A substantially elevated lifetime breast cancer risk based on a validated risk model.

Having one or more risk factors does not mean that an individual will definitely develop breast cancer. Conversely, someone without obvious risk factors can still develop the disease. This is why individualized risk assessment is important.

Importance of Individualized Breast Cancer Screening

Breast cancer screening should be based on an individual’s age, personal medical history, family history, genetic risk, and estimated lifetime risk. Mammography remains an important screening method for many women.

Women with a sufficiently high estimated lifetime risk may be candidates for additional screening, such as breast MRI. The decision to add MRI or another screening method should be based on established clinical guidelines and individual risk assessment.

Screening should also occur at evidence-based intervals. More frequent testing is not automatically better because unnecessary imaging can increase false-positive results, additional testing, anxiety, and other potential harms.

How Family History Affects Breast Cancer Risk

Family history is one of the most important components of hereditary breast cancer assessment. The relationship becomes particularly significant when multiple relatives have related cancers or when breast cancer occurs at a young age.

Healthcare professionals may ask about:

• Which family members had cancer.

• The type of cancer diagnosed.

• The age at diagnosis.

• Whether cancer occurred on the maternal or paternal side.

• Whether any relative has had genetic testing.

• Whether a known BRCA1 or BRCA2 mutation is present.

• Whether multiple generations have experienced cancer.

A detailed three-generation family history can help genetic counselors determine whether hereditary cancer testing should be considered.

BRCA1 and BRCA2 Mutations and Breast Cancer Risk

BRCA1 and BRCA2 are among the best-known genes associated with hereditary breast and ovarian cancer. Pathogenic variants in these genes can substantially increase cancer risk.

A person with a known familial BRCA mutation may benefit from genetic counseling and individualized surveillance. However, genetic testing should be interpreted carefully because results can be positive, negative, or uncertain, and each result has different implications.

A reported BRCA mutation in a close relative, as described in Paula’s case, is therefore clinically important and should prompt discussion with an appropriate healthcare professional.

Lifestyle Factors and Breast Cancer Prevention

Not all breast cancer risk factors can be changed. Age, genetics, family history, and some reproductive characteristics are examples of factors that cannot be modified.

However, certain lifestyle factors can be addressed. Maintaining a healthy weight, participating in regular physical activity, limiting alcohol, and avoiding tobacco can support overall health and may reduce the risk of several chronic diseases, including some cancers.

Lifestyle changes should complement, rather than replace, recommended cancer screening and medical care.

Conclusion

The BIO FPX 1000 Assessment 6 patient profiles of Mary, Paula, June, and Nora demonstrate why breast cancer risk assessment must be individualized. Mary’s mother’s early breast cancer diagnosis is an important hereditary-risk factor, while Paula’s sister’s reported BRCA1 mutation makes genetic counseling particularly relevant. June’s family and hormonal history should be considered alongside her ongoing screening and management of cardiovascular and bone health. Nora’s reported 23.8% lifetime risk may warrant discussion of enhanced screening and genetic counseling if the estimate comes from an appropriate validated model.

The most effective approach is to combine family history, genetic information, reproductive and hormonal history, lifestyle factors, personal medical history, and validated risk assessment tools. Healthcare professionals can then use this information to determine appropriate screening and risk-reduction strategies for each individual.

Frequently Asked Questions

What are the major breast cancer risk factors?

Major risk factors include increasing age, family history of breast cancer, inherited genetic mutations such as BRCA1 and BRCA2, certain reproductive and hormonal factors, alcohol consumption, physical inactivity, and excess body weight, particularly after menopause.

Does having a mother with breast cancer increase breast cancer risk?

Yes. Having a first-degree relative, such as a mother or sister, with breast cancer can increase an individual’s risk. The concern may be greater when the relative was diagnosed at a young age or when multiple relatives have related cancers.

What does a BRCA1 mutation mean for breast cancer risk?

A pathogenic BRCA1 variant can substantially increase the risk of breast and ovarian cancers. Individuals with a known familial BRCA1 mutation should discuss genetic counseling and individualized cancer risk management with a qualified healthcare professional.

Does hormone replacement therapy increase breast cancer risk?

Some forms of menopausal hormone therapy are associated with breast cancer risk, although the level of risk depends on factors such as the type of hormones, duration of use, and individual characteristics. Hormone therapy should be discussed with a healthcare professional rather than used or avoided solely on the basis of general risk information.

Is a 23.8% lifetime breast cancer risk considered high?

A calculated lifetime risk of 23.8% is above the commonly used 20% threshold for identifying women who may qualify for enhanced breast surveillance, such as breast MRI. However, the estimate should come from a validated risk model and should be interpreted by a healthcare professional.

How often should women have mammograms?

Mammography schedules depend on age, personal risk, and the screening guideline being followed. Women at average risk generally undergo mammography at regular evidence-based intervals. Women at substantially elevated risk may need a different screening strategy. Mammography every few weeks is not a standard screening recommendation.

Should everyone with a family history of breast cancer have genetic testing?

No. Genetic testing is not automatically necessary for everyone with a family history of breast cancer. A genetic counselor or healthcare professional can evaluate the number of affected relatives, cancer types, ages at diagnosis, known mutations, and other factors to determine whether testing is appropriate.

Can lifestyle changes prevent breast cancer?

Lifestyle changes cannot eliminate breast cancer risk, particularly when genetic or nonmodifiable factors are present. However, maintaining a healthy weight, exercising regularly, limiting alcohol, and avoiding tobacco can support overall health and may reduce the risk of breast cancer and other chronic diseases.

Why is individualized breast cancer screening important?

Breast cancer risk differs substantially between individuals. A person with a strong family history or pathogenic genetic variant may need more intensive surveillance than someone at average risk. Individualized screening helps match the intensity and timing of screening to a person’s actual risk profile.

References

American Cancer Society. (2025). Breast cancer risk factors you cannot change. https://www.cancer.org/cancer/types/breast-cancer/risk-and-prevention/breast-cancer-risk-factors-you-cannot-change.html

American Cancer Society. (2025). Breast cancer risk factors you can change. https://www.cancer.org/cancer/types/breast-cancer/risk-and-prevention/breast-cancer-risk-factors-you-can-change.html

Bardaweel, S. K., Akour, A. A., Al-Muhaissen, S., AlSalamat, H. A., & Ammar, K. (2019). Oral contraceptive and breast cancer: Do benefits outweigh the risks? A case-control study from Jordan. BMC Women’s Health, 19, 4. https://doi.org/10.1186/s12905-019-0770-x

Godinho-Mota, J. C. M., Gonçalves, L. V., Mota, J. F., Soares, L. R., Schincaglia, R. M., Martins, K. A., & Freitas-Junior, R. (2019). Sedentary behavior and alcohol consumption increase breast cancer risk regardless of menopausal status: A case-control study. Nutrients, 11(8), 1842. https://doi.org/10.3390/nu11081842

Lee, K., Kruper, L., Dieli-Conwright, C. M., & Mortimer, J. E. (2019). The impact of obesity on breast cancer diagnosis and treatment. Current Oncology Reports, 21(5), 41. https://doi.org/10.1007/s11912-019-0787-1

BIO FPX 1000 Assessment 6 Patient Case Study Profiles – Cancer Causes

National Cancer Institute. (2024). Breast cancer risk assessment. National Institutes of Health. https://www.cancer.gov/types/breast/risk-fact-sheet

National Cancer Institute. (2024). BRCA gene changes: Cancer risk and genetic testing. National Institutes of Health. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet

U.S. Preventive Services Task Force. (2024). Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. JAMA, 331(22), 1918–1930. https://doi.org/10.1001/jama.2024.5534

Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021). Breast cancer—Epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—An updated review. Cancers, 13(17), 4287. https://doi.org/10.3390/cancers13174287